Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMCS.L Regulatory News (MCS)

  • There is currently no data for MCS

Form 8.3 - MCS LN

29 Dec 2020 15:30

RNS Number : 8933J
Syquant Capital
29 December 2020
 

 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the person whose positions/dealings are being disclosed:

SYQUANT CAPITAL

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

McCarthy & Stone plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e) Date position held/dealing undertaken:

December 24th, 2020

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

NO

 

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

8p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

 

 

 

 

(2) Derivatives (other than options):

8,511,340

1.58%

 

 

(3) Options and agreements to purchase/sell:

 

 

 

 

TOTAL:

8,511,340

1.58%

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

 

 

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

8p ordinary

8p ordinary

CFD

CFD

Reducing a long position

Increasing a long position

89,078

240,138

120.00 GBp

119.80 GBp

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

 

 

 

 

 

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

N/A

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

N/A

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

December 28th, 2020

Contact name:

Laurent Boscherel

Telephone number:

+33 1 42 56 56 27

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETKKFBQNBDDABB
Date   Source Headline
1st Sep 20179:28 amRNSTotal Voting Rights
29th Aug 20173:21 pmRNSHolding(s) in Company
25th Aug 201710:33 amRNSHolding(s) in Company
15th Aug 20175:54 pmRNSHolding(s) in Company
15th Aug 201712:07 pmRNSHolding(s) in Company
9th Aug 20172:47 pmRNSHolding(s) in Company
2nd Aug 20179:34 amRNSBlock listing Interim Review
21st Jul 20179:27 amRNSHolding(s) in Company
20th Jul 20179:42 amRNSHolding(s) in Company
19th Jul 201711:58 amRNSHolding(s) in Company
18th Jul 20178:51 amRNSHolding(s) in Company
17th Jul 201710:16 amRNSHolding(s) in Company
14th Jul 20179:35 amRNSDirector/PDMR Shareholding
14th Jul 20179:27 amRNSHolding(s) in Company
13th Jul 20179:43 amRNSHolding(s) in Company
12th Jul 20172:34 pmRNSHolding(s) in Company
5th Jul 20177:00 amRNSTrading Update
4th Jul 20179:52 amRNSHolding(s) in Company
3rd Jul 201710:54 amRNSTotal Voting Rights
22nd Jun 20172:53 pmRNSHolding(s) in Company
21st Jun 20173:05 pmRNSHolding(s) in Company
14th Jun 20175:41 pmRNSDirector/PDMR Shareholding
14th Jun 201710:02 amRNSHolding(s) in Company
9th Jun 201710:07 amRNSHolding(s) in Company
6th Jun 20179:16 amRNSHolding(s) in Company
30th May 20171:32 pmRNSHolding(s) in Company
30th May 20177:00 amRNSAppointment of Chief Operating Officer
26th May 20175:10 pmRNSHolding(s) in Company
18th May 201710:23 amRNSHolding(s) in Company
17th May 20175:31 pmRNSDirector/PDMR Shareholding
15th May 201710:48 amRNSHolding(s) in Company
11th May 201711:11 amRNSHolding(s) in Company
10th May 201710:27 amRNSHolding(s) in Company
8th May 20174:33 pmRNSHolding(s) in Company
5th May 201711:03 amRNSHolding(s) in Company
4th May 20174:07 pmRNSHolding(s) in Company
3rd May 20179:50 amRNSHolding(s) in Company
2nd May 20178:51 amRNSTotal Voting Rights
2nd May 20178:26 amRNSHolding(s) in Company
27th Apr 20172:57 pmRNSHolding(s) in Company
26th Apr 201711:55 amRNSHolding(s) in Company
24th Apr 20175:27 pmRNSHolding(s) in Company
24th Apr 201712:30 pmRNSHolding(s) in Company
21st Apr 20173:22 pmRNSHolding(s) in Company
21st Apr 201710:34 amRNSHolding(s) in Company
21st Apr 201710:30 amRNSHolding(s) in Company
19th Apr 20175:19 pmRNSHolding(s) in Company
19th Apr 20179:31 amRNSDirector/PDMR Shareholding
18th Apr 20174:51 pmRNSHolding(s) in Company
13th Apr 20174:41 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.